Vitamin Shoppe, Inc (VSI)
(Delayed Data from NYSE)
$6.25 USD
-0.13 (-2.04%)
Updated May 3, 2019 04:02 PM ET
After-Market: $6.25 (%) 5:22 PM ET
NA Value
NA Growth NA Momentum NA VGMWe use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
$6.25 USD
-0.13 (-2.04%)
Updated May 3, 2019 04:02 PM ET
After-Market: $6.25 (%) 5:22 PM ET
NA Value
NA Growth NA Momentum NA VGM
Zacks News
Vitamin Shoppe (VSI) Reports Break-Even Earnings for Q3
by Zacks Equity Research
Vitamin Shoppe (VSI) delivered earnings and revenue surprises of -100.00% and -1.96%, respectively, for the quarter ended September 2019. Do the numbers hold clues to what lies ahead for the stock?
Vitamin Shoppe (VSI) Earnings Expected to Grow: What to Know Ahead of Q3 Release
by Zacks Equity Research
Vitamin Shoppe (VSI) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Rising Costs Weigh on Natural Foods Industry's Prospects
by Vidya Nair
Rising input costs are a limiting factor for companies in the natural foods space. However, favorable demand conditions are encouraging firms to expand offerings.
Zacks.com featured highlights include: Newell Brands, AZZ, Synnex, Vitamin Shoppe and GMS
by Zacks Equity Research
Zacks.com featured highlights include: Newell Brands, AZZ, Synnex, Vitamin Shoppe and GMS
5 Value Stocks With Alluring EV/EBITDA Ratios to Own Now
by Anindya Barman
We have screened value stocks based on EV/EBITDA ratio that offers a clearer picture of a company's valuation and earnings potential.
Will Vitamin Shoppe Continue to Surge Higher?
by Zacks Equity Research
As of late, it has definitely been a great time to be an investor Vitamin Shoppe.
Is Vitamin Shoppe (VSI) a Solid Pick for Value Investors?
by Zacks Equity Research
Let's see if Vitamin Shoppe (VSI) stock is a good choice for value-oriented investors right now from multiple angles.
Is Vitamin Shoppe (VSI) Stock Undervalued Right Now?
by Zacks Equity Research
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
Mondelez' Expansion Plans on Track as Buyout Spree Continues
by Zacks Equity Research
Mondelez (MDLZ) has been keen on expanding business through strategic acquisitions. Its latest buyout Perfect Snacks is another step toward bolstering offerings in the snacks division.
High Costs Dim Natural Foods Industry's Near-Term Prospects
by Vidya Nair
Companies in the natural foods space are struggling due to cost constraints. However, favorable demand conditions are encouraging firms to expand offerings.
Can 2020 Strategy Aid Clorox Despite Soft View & High Costs?
by Zacks Equity Research
Clorox (CLX) focuses on 2020 Strategy and digital efforts, as it faces the brunt of muted FY19 view.
United Natural (UNFI) Q3 Earnings Beat Estimates, Sales Miss
by Zacks Equity Research
United Natural's (UNFI) earnings top estimates while sales lag the same in third-quarter fiscal 2019. Also, management issued a drab view for the fiscal year.
Is Vitamin Shoppe (VSI) Stock Undervalued Right Now?
by Zacks Equity Research
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
Top Ranked Value Stocks to Buy for May 15th
by Zacks Equity Research
Here are four stocks with buy rank and strong value characteristics for investors to consider today, May 15th
Is Vitamin Shoppe (VSI) a Great Value Stock Right Now?
by Zacks Equity Research
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
How Vitamin Shoppe (VSI) Looks Just Ahead of Q1 Earnings
by Zacks Equity Research
Soft store comps are likely to hurt Vitamin Shoppe's (VSI) top line in Q1. However, the company's strategic efforts to enhance its store and online experience may provide a cushion to the stock.
7 Rewarding Low Price-to-Sales Stocks to Buy Right Away
by Zacks Equity Research
Price-to-sales has emerged as a convenient tool to determine the value of stocks that are incurring losses or are in an early cycle of development, generating meager or no profits.
Vitamin Shoppe (VSI) Stock Sinks As Market Gains: What You Should Know
by Zacks Equity Research
Vitamin Shoppe (VSI) closed at $7.24 in the latest trading session, marking a -0.07% move from the prior day.
Is Vitamin Shoppe (VSI) Stock Outpacing Its Retail-Wholesale Peers This Year?
by Zacks Equity Research
Is (VSI) Outperforming Other Retail-Wholesale Stocks This Year?
Zacks.com featured highlights include: G-III, Vitamin Shoppe, Tech Data and Smart & Final
by Zacks Equity Research
Zacks.com featured highlights include: G-III, Vitamin Shoppe, Tech Data and Smart & Final
Pick These 5 Bargain Stocks With Enticing EV/EBITDA Ratios
by Anindya Barman
We have screened bargain stocks based on EV/EBITDA ratio that offers a clearer picture of a company's valuation and earnings potential.
Invest Carefully Despite a Dovish Fed: 5 Safe Picks
by Nalak Das
The Fed has also reduced the growth projection of U.S. GDP, while raising its previous projection for unemployment.
New Strong Buy Stocks for March 20th
by Tirthankar Chakraborty
Here are 5 stocks added to the Zacks Rank #1 (Strong Buy) List for Wednesday
Will Vitamin Shoppe Continue to Surge Higher?
by Zacks Equity Research
As of late, it has definitely been a great time to be an investor in Vitamin Shoppe.
Top Ranked Momentum Stocks to Buy for March 6th
by Zacks Equity Research
Here are four stocks with buy rank and strong momentum characteristics for investors to consider today, March 6th